Is measurement of molecular response to therapy in bone marrow useful in children with isolated extramedullary relapse of acute lymphoblastic leukaemia?
N Hagedorn, A Schrauder, R Köhler, U zur Stadt, K Seeger, G Henze, A von Stackelberg, C Eckert · Klinische Pädiatrie · 2009 · Heft 05
Bibliografische Angaben
Zusammenfassung
In a retrospective collaborative study in children with an isolated extramedullary (IEM) relapse of acute lymphoblastic leukaemia, we demonstrated that bone marrow is involved at relapse diagnosis on submicroscopic level and this submicroscopic bone marrow involvement (SBI) revealed a prognostic impact. In a current prospective study in first IEM relapses treated according to the ALL-REZ BFM 2002 trial, SBI has been observed in 72% of patients. Therefore we have been interested, how are the reduction kinetics of SBI during treatment. We have quantified the SBI at relapse diagnosis and its reduction during therap…